RMR enters the post-earnings session with a sharp disconnect: a 25% one-month rally into results, then a Q2 print that missed on both lines.
The stock gained 8.3% on the week to close at $19.50 on May 5, extending a move that began in early April. That momentum carried the stock to a fresh 52-week high. Then, after the close on May 6, The RMR Group reported fiscal Q2 adjusted EPS of $0.11 — nine cents below consensus — and revenue of $145.6M against an estimate of $171.4M. The earnings call is scheduled for May 7. How the market digests a clean double-miss after such a run is the question that matters most right now.
Short sellers have been quietly adding exposure into this rally. Short Interest as a percentage of the free float has climbed from roughly 6.4% in late March to 7.7% today — a 19% rise in shares short over one month. The pace picked up this week: SI grew nearly 5% in the last five sessions alone, reaching approximately 1.24 million shares. That isn't panic-level positioning, but it's a steady, deliberate accumulation by bears who were evidently unconvinced by the run-up. The borrow market offers no friction to discourage them. Cost to borrow is just 0.53% annualised — essentially free — and availability is wide open, meaning there is ample room to add further short exposure without paying a squeeze premium. The ORTEX short score has drifted higher to 59.6, its highest reading in at least the past two weeks, reinforcing that directional pressure from short sellers is building rather than easing.
Options positioning adds a layer of caution to that picture. The put/call ratio is running at 1.76, modestly above its 20-day average of 1.51. That's not an extreme reading — the 52-week high reached 4.20 — but the ratio has jumped sharply from sub-1.0 levels in mid-April, when the stock was beginning its climb. Puts have been accumulating in line with the price rally, suggesting hedging activity rather than outright directional conviction. The z-score of 0.7 confirms the positioning is elevated relative to recent norms without being exceptional.
The analyst picture is thin and stale. The most recent action on record is from B. Riley Securities in mid-March, where analyst Bryan Maher kept a Buy rating but cut his target from $24 to $21 — a target the stock has now closed in on at $19.50. Ladenburg Thalmann started coverage in January with a Buy and a $17 target, a level the stock has already surpassed. With the mean price target at $19.75 and the stock trading right below it, there is essentially no implied upside from the current Street consensus. Coverage is extremely thin — two active ratings — and both targets will likely need revision after today's miss. The valuation data in the snapshot carries stale as-of dates and cannot be reliably reconciled with the current price level, so those multiples are best set aside.
Earnings history offers a limited but useful reference. The prior three confirmed prints showed a +4.8% one-day move in early May 2026, a -1.2% move in late March 2026, and a sharp +12.3% move in early February 2026 that held into a +9.4% five-day gain. The February print was the clear outlier. The March event barely moved the stock. Two beats and now a miss — with the stock coming in richly priced relative to Street targets — frames the post-earnings reaction as binary, but with the miss already public as of the May 6 close.
The earnings call on May 7 is now the immediate focus. Management commentary on fee income trends — given the $25M revenue shortfall versus estimates — and any guidance language around managed-REIT AUM will determine whether the Q2 miss reads as a structural concern or a timing issue. With short interest climbing, borrow freely available, and analyst targets sitting just above the current price, the next session will test whether the month-long rally was running ahead of the fundamentals.
See the live data behind this article on ORTEX.
Open RMR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
